Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

CV Sciences Inc.

OTC: CVSI

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
CV Sciences Inc.

Market open

CVSI
/zigman2/quotes/205511268/delayed

$

0.04

Change

+0.0018 +4.39%

Volume

Volume 45,220

Mar 21, 2023, 12:04 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205511268/delayed

Previous close

$ 0.04

$ 0.04

Change

+0.0018 +4.39%

Day low

Day high

$0.04

$0.04

Open
Open: 0.04

52 week low

52 week high

$0.03

$0.18

Open

Market cap

$6.15M

Average volume

305,553

P/E ratio

N/A

Rev. per Employee

$243,732

EPS

-0.13

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cvsi

MarketWatch News on CVSI

  2. Hemp CBD Is a Bust. Farmers Are Disappointed.

    3:40 p.m. Jan. 31, 2020

    - Barron's Online

  3. CBD Stocks Tumble After FDA Warning

    5:48 p.m. Nov. 26, 2019

    - Barron's Online

  6. 1 Marijuana Stock to Buy and 1 to Hold, According to an Analyst

    10:56 a.m. Aug. 13, 2019

    - Barron's Online

  8. CV Sciences initiated as overweight at Piper Jaffray

    8:28 a.m. Aug. 13, 2019

    - Ciara Linnane

  9. Cannabis Legalization Has Taken a Couple of Big Steps Forward

    10:30 a.m. June 3, 2019

    - Barron's Online

  10. 4 Stocks to Ride the CBD Wave

    5:25 a.m. May 22, 2019

    - Barron's Online

/news/nonmarketwatch/company/us/cvsi

Other News on CVSI

  1. 10-Q: CV SCIENCES, INC.

    5:46 p.m. Nov. 14, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. CV Sciences, Inc. (CVSI) Q3 2022 Earnings Call Transcript

    1:10 p.m. Nov. 14, 2022

    - Seeking Alpha

  4. CV Sciences Non-GAAP EPS of -$0.01, revenue of $3.75M

    10:05 a.m. Nov. 14, 2022

    - Seeking Alpha

  5. Notable earnings before Monday's open

    10:23 a.m. Nov. 11, 2022

    - Seeking Alpha

  6. CV Sciences extinguishes convertible debt

    9:33 a.m. Aug. 25, 2022

    - Seeking Alpha

  7. 10-Q: CV SCIENCES, INC.

    4:36 p.m. Aug. 15, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  13. Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates

    6:25 p.m. Aug. 4, 2022

    - Zacks.com

  14. 10-Q: CV SCIENCES, INC.

    5:15 p.m. May 16, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  17. Warning: CVSI is at high risk of performing badly

    4:33 a.m. April 7, 2022

    - Seeking Alpha

  18. 10-K: CV SCIENCES, INC.

    5:33 p.m. April 4, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  19. Warning: CVSI is at high risk of performing badly

    4:32 a.m. March 31, 2022

    - Seeking Alpha

  20. Amneal Pharmaceuticals (AMRX) Lags Q4 Earnings Estimates

    8:25 a.m. March 2, 2022

    - Zacks.com

  21. Loading more headlines...
/news/pressrelease/company/us/cvsi

Press Releases on CVSI

  1. CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels

    10:00 a.m. Today

    - PR Newswire - PRF

  5. CV Sciences, Inc. Reports Third Quarter 2022 Financial Results

    10:00 a.m. Nov. 14, 2022

    - PR Newswire - PRF

  8. CV Sciences, Inc. Extinguishes Convertible Debt

    9:00 a.m. Aug. 25, 2022

    - PR Newswire - PRF

  10. CV Sciences, Inc. Reports Second Quarter 2022 Financial Results

    9:00 a.m. Aug. 15, 2022

    - PR Newswire - PRF

  14. CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results

    4:05 p.m. March 31, 2022

    - GlobeNewswire

  19. Writing Enhancement Software Market May Set New Growth Story

    11:50 a.m. Aug. 2, 2021

    - Heraldkeepers

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.